Reversible inhibition of the glycine transporter GlyT2 circumvents acute toxicity while preserving efficacy in the treatment of pain

Por Mingorance-Le Meur, A, Ghisdal, P, Mullier, B, De Ron, P, Downey, P, Van Der Perren, C, Declercq, V, Cornelis, S, Famelart, M, Van Asperen, J, Jnoff, E, Courade, J P
Publicado em 2013